← Back to the run log

Last updated 2026-09-06standing

Jurisdictions Changelog

Append-only log of every field-level change to state/jurisdictions.json, newest first — date, jurisdiction, field, old value, new value, source URL, and whether the change was material (a verdict change).

[ { "date": "2026-09-06", "jurisdiction": "us-fl", "field": "structure", "old": "separate frontier object", "new": "record in jurisdictions array with frontier:true", "source_url": "https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/public-safety-notification-exosome-products" }, { "date": "2026-09-06", "jurisdiction": "us-fl", "field": "structure", "old": "grid record (verdict: unique)", "new": "frontier feature", "source_url": "https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/public-safety-notification-exosome-products" }, { "date": "2026-09-05", "jurisdiction": "mx", "field": "", "old": null, "new": "Added Mexico as a new jurisdiction record — see state/jurisdictions.json.", "source_url": "https://dof.gob.mx/2026/PRESREP/PRESREP_150126_02.pdf" }, { "date": "2026-09-05", "jurisdiction": "us-fl", "field": "verdict", "old": "illegal", "new": "unique", "source_url": "https://www.flsenate.gov/Session/Bill/2025/1768", "material": true }, { "date": "2026-09-05", "jurisdiction": "us", "field": "legal_basis[]", "old": null, "new": { "instrument": "FDA warning letter, Kimera Labs Inc.", "citation": "1 September 2023", "date": "2023-09-01", "summary": "FDA construed the secreted-or-extracted-human-products exclusion in 21 CFR 1271.3(d) as placing such products outside HCT/P status. Directly analogous to the SB 1768 exclusion, which borrows the same language." }, "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kimera-labs-inc-649343-09012023" }, { "date": "2026-09-05", "jurisdiction": "us-fl", "field": "legal_basis[]", "old": null, "new": { "instrument": "FDA warning letter, Kimera Labs Inc.", "citation": "1 September 2023", "date": "2023-09-01", "summary": "FDA construed the secreted-or-extracted-human-products exclusion in 21 CFR 1271.3(d) as placing such products outside HCT/P status. Directly analogous to the SB 1768 exclusion, which borrows the same language." }, "source_url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kimera-labs-inc-649343-09012023" }, { "date": "2026-09-05", "jurisdiction": "us-fl", "field": "legal_basis[instrument='SB 1768 HCT/P definition'].citation", "old": "Fla. Stat. §458.3245(1)", "new": "Fla. Stat. §458.3245(2)(a)3.", "source_url": "https://www.flsenate.gov/Laws/Statutes/2025/458.3245" } ]